These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37096652)

  • 1. Alcohol, the gut microbiome, and liver disease.
    Jew MH; Hsu CL
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1205-1210. PubMed ID: 37096652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
    Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
    Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
    Stärkel P; Leclercq S; de Timary P; Schnabl B
    Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota.
    Engen PA; Green SJ; Voigt RM; Forsyth CB; Keshavarzian A
    Alcohol Res; 2015; 37(2):223-36. PubMed ID: 26695747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
    Maccioni L; Leclercq IA; Schnabl B; Stärkel P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome as a therapeutic target in alcohol-related liver disease.
    Sarin SK; Pande A; Schnabl B
    J Hepatol; 2019 Feb; 70(2):260-272. PubMed ID: 30658727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiome Dysbiosis in Alcoholism: Consequences for Health and Recovery.
    Day AW; Kumamoto CA
    Front Cell Infect Microbiol; 2022; 12():840164. PubMed ID: 35310839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.
    Dubinkina VB; Tyakht AV; Odintsova VY; Yarygin KS; Kovarsky BA; Pavlenko AV; Ischenko DS; Popenko AS; Alexeev DG; Taraskina AY; Nasyrova RF; Krupitsky EM; Shalikiani NV; Bakulin IG; Shcherbakov PL; Skorodumova LO; Larin AK; Kostryukova ES; Abdulkhakov RA; Abdulkhakov SR; Malanin SY; Ismagilova RK; Grigoryeva TV; Ilina EN; Govorun VM
    Microbiome; 2017 Oct; 5(1):141. PubMed ID: 29041989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol, liver disease and the gut microbiota.
    Bajaj JS
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol or Gut Microbiota: Who Is the Guilty?
    Meroni M; Longo M; Dongiovanni P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases.
    Sharma SP; Suk KT; Kim DJ
    World J Gastroenterol; 2021 Oct; 27(37):6161-6179. PubMed ID: 34712025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut non-bacterial microbiota contributing to alcohol-associated liver disease.
    Gao W; Zhu Y; Ye J; Chu H
    Gut Microbes; 2021; 13(1):1984122. PubMed ID: 34711112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease.
    Addolorato G; Ponziani FR; Dionisi T; Mosoni C; Vassallo GA; Sestito L; Petito V; Picca A; Marzetti E; Tarli C; Mirijello A; Zocco MA; Lopetuso LR; Antonelli M; Rando MM; Paroni Sterbini F; Posteraro B; Sanguinetti M; Gasbarrini A
    Liver Int; 2020 Apr; 40(4):878-888. PubMed ID: 31951082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mulberry and dandelion water extracts prevent alcohol-induced steatosis with alleviating gut microbiome dysbiosis.
    Park S; Kim DS; Wu X; J Yi Q
    Exp Biol Med (Maywood); 2018 Jul; 243(11):882-894. PubMed ID: 30105955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles for the mycobiome in liver disease.
    Zeng S; Schnabl B
    Liver Int; 2022 Apr; 42(4):729-741. PubMed ID: 34995410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.